The renin-angiotensin system has been implicated in the etiology of the cardiovascular complications of diabetes. Our studies extend these findings to show a specific role for angiotensin AT1a receptors in mediating diabetes-induced hypertension. Male angiotensin AT1a knockout (AT1aKO) and wild-type (AT1aWT) mice with arterial telemetric catheters were injected with streptozotocin (STZ; 150 mg/kg ip). The STZ dose was selected on the basis of a dose-response experiment in C57/BL mice. Blood glucose, water intake, body weight, blood pressure (BP), and heart rate (HR) were measured over a 2-wk period. Estimates of BP and HR variance (BPV and HRV) and their low-and high-frequency domains were also determined. STZ induced similar levels of hyperglycemia and polydypsia in the groups. Mean arterial pressure (MAP) was increased from 100 Ϯ 6 to 124 Ϯ 6 mmHg in diabetic AT1aWT. MAP was unchanged in AT1aKO (80 Ϯ 4 vs. 85 Ϯ 5 mmHg, basal vs. STZ). Treatment with an ACE inhibitor, captopril, produced a greater reduction in MAP (Ϫ18%) in diabetic AT1aWT than in AT1aKO (Ϫ3.4%). BPV was lower in AT1aKO (19 Ϯ 0.5 vs. 9 Ϯ 2 mmHg 2 , AT1aWT vs. AT1aKO). Diabetes reduced BPV but only in AT1aWT (19 Ϯ 0.5 vs. 8 Ϯ 1 mmHg 2 , basal vs. STZ). There were no changes in HR in either group. In AT1aKO, STZ increased HRV and its high-frequency domain with no changes seen in AT1aWT. Results document that ANG AT1a receptors are critical in diabetes-induced hypertension and in cardiac autonomic responses. cardiovascular; heart rate; blood pressure; renin-angiotensin system; mice; autonomic function; streptozotocin; diabetes DIABETES MELLITUS IS A RISK factor for the development of cardiovascular disease, such as hypertension, atherosclerosis, and congestive heart failure. Mortality rates are greater in diabetic compared with nondiabetic persons, and cardiovascular disease in diabetic patients further increases the risk. The hallmark symptom for diabetes is hyperglycemia, resulting from -cell damage (Type 1) or insulin resistance (Type 2). Hyperglycemia is thought to be a major determinant in the development of longterm complications of diabetes, and treatment is focused on strict glycemic control (1, 23). However, there are interactions with the renin-angiotensin system (RAS), which contribute to diabetesinduced organ damage (8,23,43,53).The RAS plays an important role in the regulation of blood pressure and volume, mainly via the actions of ANG II. Most of the cardiovascular effects of ANG II are mediated by AT1 receptors, which are present in vasculature, brain, heart, and other tissues. AT1 receptors exist as two subtypes, AT1a and AT1b, in mice and rats (33). Studies of the functional role of AT1a receptors have relied on gene deletion (30) or gene silencing (5) methods, because it is not possible to pharmacologically distinguish AT1 receptors. ANG AT1a-deficient mice show low blood pressure, altered renal and autonomic function, and increased sodium sensitivity (6,30,45,46,49,50).Diabetes is associated with activation of the RAS in both h...